Stanley Schrier, Stanford University Medical Center

Stanley Schrier, Stanford University Medical Center

Close modal

The lefthand panel is a peripheral smear from a patient who developed a hemolytic anemia while taking Pyridium (phenazopyridine). She was supposed to take it for 3 days for bladder discomfort but continued taking it for almost a month. Note the “bite cells,” which are abnormal red blood cells (RBCs) that look like a bite has been taken out; other names are hemiblister or cross-linked cells. The drug causes oxidant damage to the RBC membrane and hemoglobin, leading to accelerated removal of the affected RBCs. The righthand panel is a positive Heinz-body preparation from the patient. The supravital stain of the peripheral blood with new methyl violet detects oxidatively denatured hemoglobin. Splenic removal (pitting) of the denatured hemoglobin may produce the “bites” seen in the first panel.

Sign in via your Institution